Thomas J. Herzfeld Advisors’s Medtronic MDT Stock Holding History

Thomas J. Herzfeld Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-262	Closed	-$20.5K	–	261
2023 Q3	$20.5K	Hold	262	–	–	0.01%	149
2023 Q2	$23.1K	Sell	262 -16	-6%	-$1.38K	0.01%	141
2023 Q1	$22.4K	Sell	278 -17	-6%	-$1.39K	0.01%	122
2022 Q4	$22.9K	Sell	295 -2	-0.7%	-$162	0.01%	127
2022 Q3	$24K	Hold	297	–	–	0.01%	121
2022 Q2	$27K	Hold	297	–	–	0.01%	127
2022 Q1	$33K	Buy	297 +200	+206%	+$21.1K	0.01%	135
2021 Q4	$10K	Buy	97 +14	+17%	+$1.62K	﹤0.01%	206
2021 Q3	$10K	Buy	83 +10	+14%	+$1.29K	﹤0.01%	192
2021 Q2	$9K	Hold	73	–	–	﹤0.01%	216
2021 Q1	$9K	Hold	73	–	–	﹤0.01%	205
2020 Q4	$9K	Hold	73	–	–	﹤0.01%	209
2020 Q3	$7K	Hold	73	–	–	﹤0.01%	170
2020 Q2	$7K	Sell	73 -16	-18%	-$1.53K	﹤0.01%	208
2020 Q1	$8K	Buy	89 +18	+25%	+$1.92K	﹤0.01%	181
2019 Q4	$8K	Hold	71	–	–	﹤0.01%	211
2019 Q3	$8K	Buy	+71	New	+$7.41K	﹤0.01%	223

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Thomas J. Herzfeld Advisors's MDT Position: Q4 2023 in Review

Thomas J. Herzfeld Advisors sold out of Medtronic (MDT) in Q4 2023, closing a stake of 262 shares — an estimated $20.5K sold.

Thomas J. Herzfeld Advisors first reported a position in MDT in Q3 2019 and held it in 17 quarters. The position peaked at $33K in Q1 2022. 2,077 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

Thomas J. Herzfeld Advisors reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
Thomas J. Herzfeld Advisors sold 262 Medtronic shares in Q4 2023, an estimated $20.5K.
Thomas J. Herzfeld Advisors first reported a position in Medtronic in Q3 2019 and held it in 17 quarters.
Thomas J. Herzfeld Advisors's Medtronic position peaked at $33K in Q1 2022.
2,077 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on Thomas J. Herzfeld Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.